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Autophagy lipidation machinery regulates axonal
microtubule dynamics but is dispensable for
survival of mammalian neurons
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M. Lammers 3, V. Kondylis 1, I. Neundorf 4 & N.L. Kononenko1✉
Neurons maintain axonal homeostasis via employing a unique organization of the micro-
tubule (MT) cytoskeleton, which supports axonal morphology and provides tracks for
intracellular transport. Abnormal MT-based trafficking hallmarks the pathology of neurode-
generative diseases, but the exact mechanism regulating MT dynamics in axons remains
enigmatic. Here we report on a regulation of MT dynamics by AuTophaGy(ATG)-related
proteins, which previously have been linked to the autophagy pathway. We find that ATG
proteins required for LC3 lipid conjugation are dispensable for survival of excitatory neurons
and instead regulate MT stability via controlling the abundance of the MT-binding protein
CLASP2. This function of ATGs is independent of their role in autophagy and requires the
active zone protein ELKS1. Our results highlight a non-canonical role of ATG proteins in
neurons and suggest that pharmacological activation of autophagy may not only promote the
degradation of cytoplasmic material, but also impair axonal integrity via altering MT stability.
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M icrotubules (MTs) play a fundamental role in themaintenance of axonal homeostasis by preservingaxonal morphology and providing tracks for protein
and organelle transport1. Unlike dendritic MTs, which exhibit a
bidirectional polarity, axonal MTs are composed of pre-
dominantly plus-end-out oriented multimers of α-tubulin and β-
tubulin heterodimers2. Although the majority of axonal MTs are
more stable than the MTs of dendrites, axons also possess a
fraction of shorter, dynamic MTs that undergo phases of growing
(polymerization) and shrinking (depolymerization), a process
known as dynamic instability3. This dynamic property of MTs is
regulated by the intrinsic GTPase activity of tubulin, their asso-
ciation with MT-associated proteins (MAPs) and motor pro-
teins4, as well as by diverse MT posttranslational modifications
(PTM), including acetylation, tyrosination and detyrosination5.
The function of stable MTs in neurons is well studied and
includes their pivotal role in providing tracks for long-distance
transport1. In contrast, the purpose of dynamic MTs in otherwise
extremely polarized neurons is not completely understood. It is
believed that dynamic MTs act as sensors of cellular micro-
environment, allowing the rapid reorganization of the cytoske-
leton6, required for synaptic plasticity and axonal regeneration7,8.
Furthermore, since most axons are lifelong sustained, continued
MT turnover is needed to prevent senescence through mechanical
wear and to remove irreversible PTMs9. Given these prominent
roles of MTs, it is not surprising that the tight regulation of stable
versus dynamic equilibrium of MTs is pivotal for neuronal
function. Dysregulation of MT dynamics is implicated in the
majority of neurodegenerative disorders10. An increase in MT
stability also correlates with decreased neuronal plasticity, which
is known to occur during aging11. Although understanding the
fine regulation of MT dynamics is crucial to unravel the etiology
of neurodegeneration, the precise mechanism that regulates the
equilibrium between dynamic and stable MTs in axons is cur-
rently unknown.
Axonal degeneration is also associated with aberrant autop-
hagic activity. Autophagy is an evolutionary conserved process
that provides nutrients during starvation and eliminates defective
proteins and organelles via lysosomal degradation12. The most
prevalent form of autophagy is macroautophagy, and during
this process, portions of the cytoplasm are sequestered within
double-membraned vesicles termed autophagosomes. These
undergo subsequent maturation steps before being delivered to
the lysosomes for degradation. Autophagy plays important
roles in maintaining cellular homeostasis13, and its dysfunction
causes neurodegeneration characterized by axonal pathology14
and accumulation of insoluble ubiquitin (Ub)-positive and
Sequestosome-1 (SQSTM1, p62)-positive protein inclusions15,.
Intriguingly, prevention of inclusion formation by p62 ablation
does not suppress neurodegeneration in autophagy-deficient
mice16, challenging a toxic role for inclusions in neurons and
raising the question of precise physiological function of autop-
hagy in the brain.
Autophagy induction depends on the activity of the ATG1/
ULK1 and PI3KC3 complex I, while autophagosome formation
requires two ubiquitin (Ub)-like conjugation machineries13. The
Ub-like ATG12 conjugates with ATG5 (ATG12~ATG5), which
further establishes a complex with ATG16L (ATG12~ATG5/
ATG16L). E3-like activity of ATG12~ATG5/ATG16L catalyzes
the lipid conjugation of Ub-like ATG8 family proteins, including
MT-associated protein 1 light chain 3 (LC3) to autophagosomal
membrane-resident phosphatidylethanolamine (PE)17. An
important step for PE conjugation of ATG8 is its (pre-)processing
by the cysteine protease ATG4, which exposes a C-terminal
glycine residue essential for lipid conjugation18. Although cano-
nically LC3 lipidation has been associated with the autophagy
pathway, recently this modification has been reported to occur
during autophagy-unrelated processes19. For instance, in non-
neuronal cells LC3 can be attached to the plasma membrane
during virus infection20 or it can be conjugated to endolysosomal
membranes21. However, whether in neurons the LC3 lipidation
machinery is exclusively involved in autophagy-associated protein
degradation is currently unknown.
Here, we demonstrate that ATG proteins involved in lipid
conjugation of LC3 are dispensable for survival of excitatory
neurons and instead regulate the stability of axonal MTs inde-
pendently of their role in canonical autophagy. Deleting ATG5 or
ATG16L1 or increasing the availability of non-lipidated LC3 by
using a mutant form of cysteine protease ATG4B causes the
formation of axonal swellings due to impaired MT dynamics, a
phenotype that hampers the transport of axonal cargo and
compromises learning and memory-dependent neuronal activity.
Our data demonstrate a function of the ATG lipidation
machinery in neurons and suggest that modulation of autophagy
activity in the brain may not only promote the degradation of
bulk cytoplasmic material, but also impair axonal integrity via
altering MT dynamics.
Results
Excitatory neurons survival does not require ATG5 or
ATG16L1. Since ablation of inclusion bodies in mice with
impaired LC3 lipidation does not prevent neurodegeneration16,
we sought to investigate the exact mechanism by which the
autophagy lipid conjugation machinery regulates neuronal func-
tion. To this end, we first eliminated the crucial autophagy
component ATG5 in forebrain excitatory neurons by cross-
breeding the Atg5flox/flox mice with CamKIIα-Cre mice22
(Fig. 1a, Supplementary Fig. 1a). Atg5flox/flox:CamKIIα-Cre
(ATG5 KO) mice were viable, but revealed a cessation of
weight gain starting at about one month of age when compared to
their WT littermates (Supplementary Fig. 1b). In agreement with
published data23, the amount of LC3 at autophagosomal mem-
branes, monitored via LC3II (lipidated LC3) levels, was sig-
nificantly downregulated (Fig. 1b, Supplementary Fig. 1c), while
p62 was significantly increased in the cortex of mice lacking
ATG5 (Supplementary Fig. 1e, f). Since autophagy is required for
cellular survival15 and apoptosis-related loss of neurons is
described in several autophagy-deficient mouse models24, we
analyzed apoptotic signaling in forebrain excitatory ATG5 KO
neurons. Surprisingly, the survival of neurons in the cortex and
the hippocampus of 13-week-old mice was not affected by the
ATG5 deletion (Fig. 1c–f). The lack of apoptosis in ATG5 KO
brains was supported by the absence of cleaved caspase3 activity
(Fig. 1g), a phenotype which was reproduced in an in-vitro cor-
tico-hippocampal culture system, where the deletion of ATG5
was driven via a tamoxifen-dependent activation of the CAG-Cre
promoter (Fig. 1h, i, Supplementary Fig. 1g–i). The survival-
dispensable role of ATG5 in neurons was further confirmed by
non-significant changes in the gene expression levels of pro-
survival and pro-apoptotic genes (Fig. 1j). To elucidate whether
this phenotype was a mere function of ATG5 or a more general
phenomenon associated with a defective LC3 lipidation
machinery, we deleted ATG16L1, another component of the LC3
lipid conjugation system (Fig. 1k, Supplementary Fig. 1j). In
agreement with the data from the ATG5 KO mice, ATG16L1 was
also dispensable for survival of cortical neurons in-vitro (Fig. 1l)
and in-vivo (Fig. 1m, n).
LC3 lipidation machinery maintains axonal homeostasis. Even
though ATG5 was dispensable for neuronal apoptotic signaling,
ATG5 KO mice were characterized by increased postnatal
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Fig. 1 Survival of excitatory neurons is dispensable of ATG5 and ATG16L1. a ATG5 protein levels in cortical brain lysates from 13-weeks-old WT and
ATG5 KO mice. b LC3 lipidation is defective in ATG5 KO brains. c–f Histopathological analysis of Nissl-stained brain sections of ATG5 KO brains reveals
unaltered number of cortical (c, d) (WT: 0.0026 ± 0.0002, KO: 0.0022 ± 0.0001. p= 0.163) and hippocampal neurons (e, f) (WT: 0.0028 ± 0.0003, KO:
0.0026 ± 0.0002. p= 0.465), N= 4 independent experiments each. Rectangular box in e depicts the hippocampal area used for quantification. Scale bars,
200 µm. g Representative confocal images of cortical brain sections from WT and ATG5 KO mice immunostained for cleaved Caspase-3 (CASP3, green)
and co-immunostained for p62 (magenta). Rectangular boxes indicate areas magnified to the right. Circles in the KO indicate cells positive for p62, but
negative for CASP3. Scale bars, 200 µm. h Immunoblot illustrating cleaved CASP3 levels in lysates from cultured neurons, as well as in cortical lysates from
WT and ATG5 KO mice. HEK293T cells treated with H2O2 were used as a positive control. i Analysis of cellular viability using the Live/Dead cell assay in
WT and ATG5 KO cultured neurons (WT: 97.55 ± 0.60%, KO: 95.25 ± 3.04%, p= 0.499, N= 3 independent experiments). j Bcl-xl, c-Flip, Bax, and Chop
mRNA levels in cultured WT and ATG5 KO neurons. N= 5 independent experiments. mRNA levels were normalized to the levels of housekeeping gene
Tbp set to 100%. k ATG16L1 protein levels in lysates from cultured WT and ATG16L1 KO neurons. l Cleaved CASP3 levels in lysates from cultured WT and
ATG16L1 KO neurons, starved for 16 h or left untreated. HEK293T cells treated with H2O2 were used as a positive control. m, n Histopathological analysis
of Nissl-stained cortical sections of ATG16L1 deficient brains at 13-weeks reveals no morphological alterations and unchanged number of neurons (WT:
0.0021 ± 0.0001, KO: 0.0023 ± 0.0001, p= 0.354, N= 3 independent experiments). Scale bar, 200 µm. All graphs show mean ± SEM, statistical analysis
was performed by unpaired two-tailed Student’s t-test. n.s.-non-significant. Source data are provided as a Source Data file.
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lethality (Supplementary Fig. 2a). To obtain further insights into
neuronal function of ATG5 we analyzed the morphology of 13-
week-old KO brains in detail. Although the anatomy of the cortex
and the hippocampus was not altered by the ATG5 deletion (see
Fig. 1), we detected a substantial loss of neurons in the thalamus
(the posterior and ventral nuclei) (Supplementary Fig. 2b), an
area, which is not targeted by the activity of Cre expression-
driving CamKIIα promoter (Supplementary Fig. 2c). Since tha-
lamic atrophy occurs in a number of axonal dystrophy-associated
diseases25,26, we hypothesized that structural changes observed in
ATG5 KO thalamus were caused by the degeneration of long-
range corticothalamic axons. To test this hypothesis, we labeled
efferent projections of cortical deep layer neurons to the thalamus
via stereotactic injection of an adeno-associated virus, expressing
GFP under CamKIIα promoter (AAV-GFPCamKIIα, Fig. 2a).
Indeed, corticothalamic axons of ATG5-deficient neurons
revealed signs of severe axonal degeneration, characterized by en-
passant swellings (Fig. 2b, c). Appearance of axonal swellings,
termed axonal spheroids, was also reproduced in in-vitro ATG5
deficient cortico-hippocampal culture system (Fig. 2d, Supple-
mentary Fig. 2d), where about 30% of neurons displayed signs of
axonal injury (Fig. 2e, Supplementary Fig. 2e) mostly confined to
a b c d
AAV-GFPCamKII
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presynaptic terminals (Fig. 2f). This phenotype was rescued by re-
expression of ATG5-eGFP (Fig. 2e). Neither dendritic morphol-
ogy, nor spine density were affected by the ATG5 deletion
(Supplementary Fig. 2f, g). Axonal swellings were also evident in
about 24% of cultured ATG16L1 KO neurons (Fig. 2g, h) and in
neurons overexpressing an inactive C74A form of ATG4B27,
which inhibits the lipidation of LC3 (Fig. 2i, j). In contrast,
deletion of ULK-interacting protein FAK-family kinase-interact-
ing protein of 200 kDa (FIP200), a manipulation that prevents
autophagy induction, not directly affecting the levels of cyto-
plasmic LC328, was not sufficient to cause the formation of axonal
swellings (Fig. 2k, Supplementary Fig. 2h, i). These data indicate
that LC3 lipidation machinery regulates axonal homeostasis and
suggest that the increased abundance of cytoplasmic LC3 (LC3I)
in the absence of ATG5 and/or ATG16L1 (Fig. 2l–o, see also
Supplementary Fig. 1d for in-vivo levels) might be responsible for
the appearance of swellings in axons. In agreement with this
hypothesis, axonal degeneration was observed in control neurons
overexpressing the lipidation-deficient mutant of LC3B (G120A),
but was absent in neurons overexpressing the WT LC3 (Fig. 2p, q,
Supplementary Fig. 2j), suggesting that under control conditions
the autophagy lipidation machinery maintains the equilibrium
between cytoplasmic and lipidated LC3 isoforms. In fact, shifting
the balance towards cytoplasmic LC3 by treating the eGFP-LC3B
transgenic neurons (Supplementary Fig. 2k) with cell membrane
permeable LC3B peptide, which would titrate ATG4 in a
dominant-negative manner and increase the availability of cyto-
plasmic LC3B, mimicked the axonal pathology phenotype (Sup-
plementary Fig. 2l, m). Finally, downregulation of LC3B, using a
smart pool of short interfering (si) RNAs directed against Lc3b,
diminished axonal pathology in ATG5 KO neurons (Fig. 2r, s,
Supplementary Fig. 2n, o).
Degeneration of KO axons is protein inclusions-independent.
What is the mechanism by which loss of autophagy lipidation
machinery causes axonal dystrophy? Accumulation of protein
aggregates and/or aberrant pre-autophagosomal structures29 is a
classical hallmark of defective autophagy. We thus hypothesized
that axonal degeneration is caused by defective clearance of ubi-
quitinated proteins and stalled pre-autophagosomal intermediates
in axonal terminals. To test this, we first examined the levels of the
autophagy receptor p62/SQSTM1 and ubiquitin in soma and axons
of autophagy-deficient neurons by immunocytochemistry. While
massive accumulation of cytoplasmic p62-positive inclusions was
observed in the soma of ATG5 and ATG16L1 KO neurons
(Fig. 3a–e, Supplementary Fig. 3a, b), axons of autophagy-deficient
neurons or neurons overexpressing the C74A mutant of ATG4B
were devoid of ubiquitin and p62 inclusions (Fig. 3f–h, Supple-
mentary Fig. 3c–f). Next, we analyzed pre-autophagosomal struc-
tures in KO neurons using antibodies recognizing early
autophagosomal intermediates. In agreement with unaltered levels
of FIP200, ATG13, WIPI2 in KO lysates (Supplementary Fig. 3g),
we found that KO swellings did not accumulate early autophago-
somal intermediates (Supplementary Fig. 3h–o). The levels of
ATG9 and WIPI2 were even significantly lower in KO axons, likely
due to impaired membrane trafficking from the soma (Supple-
mentary Fig. 3i, o). These results are in line with previously pub-
lished data, revealing the neurodegeneration in protein inclusion-
free ATG7 KO brains16 and strongly suggest that axonal pathology
in neurons lacking LC3 lipid conjugation machinery is caused via
protein inclusions-independent mechanism.
KO axons accumulate components of trafficking machinery.
Next, we hypothesized that axonal swellings might represent
distended synapses, formed either due to defective synaptic
vesicles (SV) exocytosis or as a result of impaired vesicular traf-
ficking. To test the first hypothesis, we employed the pH-sensitive
fluorescent protein pHluorin fused to the Synaptobrevin2 (SYB2),
which is widely used as a reporter of SV exocytosis30. Analysis of
SYB2-pHluorin decay fluorescence upon stimulation with 200
action potentials at 50 Hz revealed that autophagy-deficient
neurons are still capable of undergoing SV exocytosis (Supple-
mentary Fig. 3p).
Ultrastructural studies indicate that axonal dystrophy is often
accompanied by the accumulation of membranous organelles31,
including mitochondria and late endosomes32,33. In fact, we
found that ATG5 KO presynaptic terminals examined by electron
microscopy (EM) accumulated late endosomal organelles (Fig. 3i)
and functional mitochondria (Supplementary Fig. 3q–s), a
phenotype, which was confirmed by immunostaining with late
endosomal marker RAB7 (Fig. 3j, k). Levels of RAB7 in the soma
of ATG5 KO neurons were not altered (Supplementary Fig. 3t).
Since RAB7 is known to play an essential role in the MT-based
axonal transport34, we hypothesized that axonal swellings in
autophagy-deficient neurons might result from defective MT-
based trafficking of intracellular cargo. To elucidate this
hypothesis, we first examined the levels of MT-associated dynein
activator Dynactin1 (DYNC1) in axonal spheroids of ATG5 KO
neurons. Our data revealed that while in control condition
DYNC1 showed a homogeneous cytosolic appearance along the
Fig. 2 Loss LC3 lipidation machinery causes axonal neurodegeneration. a Schematic illustration of stereotaxic delivery of AAV9-GFPCamKIIa into deep
layers of primary motor cortex. b, c Loss of ATG5 causes en-passant swellings of long-range projection axons. Scale bar, (b) 200 µm, (c) 10 µm. d eGFP-
transfected WT and ATG5 KO neurons immunostained for MAP2 and SYB2. Scale bar, 50 µm. e Percentage of WT and ATG5 KO neurons revealing axonal
swellings when transfected either with eGFP (WT: 4.60 ± 1.09%, KO: 32.82 ± 3.70%) or with ATG5-eGFP (WT: 7.47 ± 2.60%, KO: 7.18 ± 2.20%).
**pWTGFP vs. KOGFP= 0.001, **pWTATG5 vs. KOATG5= 0.002. N= 3 independent experiments. f Axonal swellings are mostly found at presynapses
(58.62 ± 0.81%). g, h Percentage of eGFP-transfected WT and ATG16L1 KO neurons with axonal swellings (WT: 6.05 ± 2.14%, KO: 23.85 ± 1.24%), **p=
0.004, N= 3 independent experiments. Scale bars: 10 µm, inserts 2 µm. i, j Percentage of mCherry-ATG4BC74A or pmStrawberry-ATG4BC74A (green)-
transfected neurons revealing axonal swellings (mCherry: 4.03 ± 0.25%, pmStrawberry-Atg4BC74A 11.60 ± 1.22%). **p= 0.008. N= 3 independent
experiments. Scale bars: 10 µm, inserts 2 µm. k Percentage of axonal swellings in neurons with Fip200 siRNA-mediated KD (scr:4.46 ± 2.40%, siRNA:5.78
± 2.87%). p= 0.659. N= 4 independent experiments. l–o LC3I protein levels are significantly increased in ATG5 KO (1.91 ± 0.35, *p= 0.023, N= 6
independent experiments) and ATG16L1 KO (1.23 ± 0.08, *p= 0.04, N= 4 independent experiments) lysates, compared to WT controls set to 1.
p, q Percentage of ptagRFP-LC3B (proLC3)- or ptagRFP-LC3B G120A-expressing neurons with axonal swellings (ptagRFP- LC3B: 6.29 ± 0.30%, ptagRFP-
LC3B G120A: 19.16 ± 2.50%). *p= 0.014. N= 3 independent experiments. Neurons were co-transfected with eGFP to visualize the axons. Scale bars: 4 µm,
kymographs, 5 µm× 20 s. r, s Knockdown of LC3B in ATG5 KO neurons significantly decreases axonal spheroid area (KOscr: 4.57 ± 0.06 µm2, KOsiLC3b2.78
± 0.20 µm2). **p= 0.001. N= 3 independent experiments. eGFP-expressing ATG5 KO neurons were treated either with scramble siRNA (scr) or LC3b
siRNA and immunostained for LC3. Circles indicate en-passant axonal swellings. Scale bars: 5 µm. All graphs show mean ± SEM, statistical analysis was
performed by unpaired two-tailed Student’s t‐test in (h, j, k, q, s), two-way ANOVA for multiple comparisons in (e) and by one-sample Student’s t‐test in
(m, o). n.s.-non-significant. Total number of neurons in N experiments is shown in Supplementary Table 3. Source data are provided as a Source Data file.
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axons, ATG5 KO axons revealed large 5–10 µm spheroid-like
accumulations of DYNC1 (Fig. 3l, m). Furthermore, in agreement
with the presence of endosome-like membrane organelles at the
KO synapse, we found that KO swellings revealed an increased
colocalization of DYNC1 with activated tropomyosin-related
kinase receptor B (TRKB) receptors (Fig. 3n, o, Supplementary
Fig. 3u), a known cargo of dynein motors in axons35. This
phenotype was specific to MT-based axonal cargo, since the
localization of presynapse-confined SV protein SYB2 was not
altered by the ATG5 deletion (Supplementary Fig. 3v, w).
To obtain further insights into the ATG5 function in transport
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TRKB receptor (TRKB-mRFP) by live imaging (Fig. 3p, q). We
found that while in control neurons TRKB-mRFP puncta displayed
bidirectional dynein-dependent movement (Supplementary Fig. 3x,
y) with a velocity between 0.3–0.4 µm * s−1, ATG5 deletion
significantly diminished the mobile fraction of retrograde and
anterograde TRKB carriers (Fig. 3r) and caused a significant
reduction in the retrograde velocity of TRKB receptors (Fig. 3s). Of
note, the TRKB velocity was faster in young neurons than that of
mature neurons (Supplementary Fig. 3z). Similar results were
obtained by analyzing the axonal transport of mitochondria in
ATG5-deficient neurons (Supplementary Fig. 3a′, b′). Taken
together, these results demonstrate that axonal pathology in
neurons lacking the LC3 lipid conjugation machinery is accom-
panied by the distal accumulation of components of MT-based
trafficking machinery.
LC3 lipidation machinery regulates MT dynamics in neurons.
Our findings above raise the question of whether the LC3 lipi-
dation machinery directly regulates tubulin dynamics. The fun-
damental difference between dendrites and axons is the extent of
“MT dynamic instability”. While dendrites contain equal
amounts of stable and dynamic MTs, axonal MTs are mostly
stable at the axonal shaft and labile at the en passant presynaptic
terminals36. Given the fact that the pathology in autophagy
deficient neurons is most evident at presynaptic axonal boutons,
we next asked whether disruption of ATG5 alters the dynamic
properties of axonal MTs. To this aim, we analyzed MT poly-
merization events in control and ATG5 KO axons, transfected
with plus-end MT binding protein EB3-dtTomato (Fig. 4a, b), a
reporter of MT polymerization events (comets)37. We found that
while in control condition EB3-positive comets were evident
along the axons, the overall number of EB3-positive comets was
severely reduced under autophagy-deficient condition, a pheno-
type rescued after re-expression of ATG5 (Fig. 4c). Next, we
probed the total amount of dynamic MTs in ATG5 KO neurons,
by extracting the labile MTs and analyzing the levels of total α-
tubulin, as well as detyrosinated (stable MTs) and tyrosinated
(dynamic MTs) α-tubulin by Western blotting. As shown in
Fig. 4d, e, the total amount of dynamic MT was significantly
reduced under autophagy-deficient conditions.
A prediction from these data is that ATG5 KO neurons reveal
generally higher levels of stable MTs, which in neurons are
known to be posttranslationally modified to detyrosinated and Δ2
α-tubulin (lacking two C-terminal amino acids). As predicted the
amount of Δ2 α-tubulin was significantly upregulated in neurons
lacking ATG5 (Fig. 4f–h). Furthermore, ATG5 KO neurons
revealed higher levels of acetylated tubulin (Supplementary
Fig. 4a, b) and were resistant to nocodazole treatment
(Supplementary Fig. 4c, d), a drug which induces MT
disassembly. Total levels of α-tubulin were altered neither in
ATG5 nor in ATG16L1 KO neurons (Supplementary Fig. 4e–h).
Finally, we separated polymerized MTs from soluble fraction of
tubulin (monomers and dimers) in cultured ATG5 KO neurons
and analyzed the MT fractions as above (Fig. 4i). We found that
level of stable MTs was significantly increased in autophagy-
deficient neurons, while the labile MTs, probed by an antibody
against the tyrosinated tubulin, were reduced (Fig. 4j).
Taking into account the effect of other components of LC3
lipidation machinery on the formation of axonal swellings (see
also Fig. 2q, r), we next analyzed MTs stability in ATG16L1 KO
neurons. Similarly to ATG5 deficient neurons, ATG16L1 KO cells
revealed higher levels of Δ2 α-tubulin (Fig. 4k–m), while the
overall number of EB3-positive comets was significantly reduced
(Fig. 4n–p). ATG16L1 deficient neurons were also resistant to
nocodazole treatment (Supplementary Fig. 4i). EB3-positive
comet density was additionally decreased in wild type neurons
overexpressing LC3B G120A, but not in cells overexpressing
LC3B wildtype (Fig. 4q, r) or lipidation-deficient GABARAP
(Fig. 4s, t).
Cytoplasmic LC3A/B associate with ELKS1 in the brain. The
data described thus far suggest a model according to which the
levels of cytoplasmic LC3 regulated via autophagy lipidation
machinery fine-tune the MT dynamics in neurons. Given that
LC3 was originally identified as a MT-binding protein, which can
both indirectly and directly associate with tubulin and MTs38–40,
we hypothesized that hyperstable MTs found in neurons under
autophagy-deficient conditions are the result of increased asso-
ciation of LC3 with neuronal tubulin. To probe this hypothesis,
we carried out co-immunoprecipitation experiments using solu-
ble and polymerized MT fractions isolated from ATG5 WT and
KO neurons. Although a small amount of LC3 was found to be
co-immunoprecipitated with α-tubulin in the soluble MT frac-
tion, we could not detect an upregulation of LC3 association with
MTs in absence of ATG5 (Supplementary Fig. 5a, b). Thus, the
MT stability phenotype under ATG5-defective conditions does
not appear to result from increased LC3 association with neu-
ronal tubulin.
To further dissect the molecular mechanism underlying the
regulation of MT dynamics by cytoplasmic LC3 we performed
mass spectrometry analysis of LC3 binding partners in the adult
mouse brain (Fig. 5a, Supplementary Fig. 5c, see also data
Fig. 3 Axonal swellings in autophagy-deficient neurons contain components of MT-based trafficking machinery. a, b p62 levels in lysates from cultured
WT, ATG5 KO (a) or ATG16L1 KO (b) neurons. c–e Analysis of p62-containing puncta in somata of ATG5 KO and ATG16L1 KO neurons, immunostained for
MAP2 (magenta) (WTATG5: 0.007 ± 0.001, KOATG5: 0.023 ± 0.002, **p=0.001; WTATG16L1: 0.013 ± 0.002, KOATG16L1: 0.045 ± 0.007, **p=0.009), N= 3
independent experiments. Scale bars: 5 µm. f–h Analysis of p62-containing puncta in axons of ATG5 KO and ATG16L1 KO eGFP-transfected neurons
(WTATG5: 0.009 ± 0.001, KOATG5: 0.012 ± 0.002, p= 0.131; WTATG16L1: 0.018 ± 0.002, KOATG16L1: 0.015 ± 0.005, p=0.545), N= 3 independent
experiments. Scale bars: 5 µm. i Electron micrographs of WT and ATG5 KO synapses. Endosomal intermediates are marked by red arrows. Scale bar: 200 nm.
j, k RAB7 puncta density in WT and ATG5 KO axons (KO: 148.84 ± 15.63%). *p=0.044. N= 3 independent experiments. Fluorescent levels in the KO were
normalized to the WT set to 100%. Scale bars (j): 10 µm, 2 µm inserts. l, m DYNC1 puncta density in WT and ATG5 KO axons (KO: 133.26 ± 2.53%). **p=
0.003. N= 3 independent experiments. Fluorescent levels in the KO were normalized to theWT set to 100%. Scale bars (l): 10 µm, 2 µm inserts. n, o Confocal
images (n) and fluorescent profiles (o) of WT and ATG5 KO neurons immunostained for DYNC1 and phosphorylated TRKB receptors (pTRKB). Scale bars: 30
µm, 10 µm inserts. p, q Time-lapse images and corresponding kymographs of TRKB-mRFP-expressing WT and ATG5 KO neurons. Scale bars: x: 5 µm, y: 10 s.
r Loss of ATG5 significantly decreased the mobility of TRKB carriers compared to WT controls (WTRetro: 20.99 ± 2.63%, KORetro: 13.23 ± 1.09%, WTAntero:
20.00 ± 1.72%, KOAntero: 13.22 ± 1.97%). *pRetro=0.034, *pAntero=0.041, N= 4 independent experiments. s Loss of ATG5 significantly decreased the
retrograde TRKB velocity compared to WT controls (WTRetro: 0.32 ± 0.02 µm * s−1, KORetro: 0.22 ± 0.01 µm * s−1, WTAntero: 0.29 ± 0.01 µm * s−1, KOAntero:
0.28 ± 0.03 µm * s−1). **pRetro=0.004, pAntero= 0.721. N= 4 independent experiments. All graphs show mean ± SEM, statistical analysis was performed by
unpaired two-tailed Student’s t‐test in (e, h, r, s) and one-sample Student’s t‐test in (k, m). n.s.-non-significant. Total number of neurons in N experiments is
shown in Supplementary Table 3. Source data are provided as a Source Data file. m.g.v-mean gray value.
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deposited in the ProteomeXchange, #PXD011279). In agreement
with the data from cultured neurons, we failed to detect specific
binding of neuronal LC3 to tubulin subunits in the brain
(Supplementary Fig. 5e–k). Interestingly, we identified a protein
called ELKS1 (glutamic acid/leucine/lysine/serine-rich protein,
also known as RAB6IP2, CAST2 or ERC141), as a putative
interactor of LC3 in the brain (Fig. 5a, Supplementary Fig. 5d).
ELKS1 is a scaffolding protein, which is ubiquitously expressed in
all tissues, but is most abundant in neurons, where it is enriched
at the presynaptic active zone (AZ)42 (Supplementary Fig. 6a,b).
To determine the role of LC3 homologs in the regulation of
ELKS1 function, we first analyzed their interactions using co-
immunoprecipitation assays and colocalization studies. Ectopi-
cally expressed ELKS1, tagged with tdTomato was co-
immunoprecipitated with eGFP tagged LC3A and LC3B, but






























































































































































ATG16L1 WT ATG16L1 KO














































































































































































ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-020-15287-9
8 NATURE COMMUNICATIONS |         (2020) 11:1535 | https://doi.org/10.1038/s41467-020-15287-9 | www.nature.com/naturecommunications
unlipidated LC3A G120A and LC3B G120A bind ELKS1, with a
stronger preference of LC3B G120A for ELKS1 (Fig. 5e, f), while
the absence of binding was detected when the lipidation-deficient
GABARAP was used as a bait (Fig. 5g). Reciprocally, eGFP-LC3A
and eGFP-LC3B were co-immunoprecipitated with tdTomato-
ELKS1 (Fig. 5h, i). Subsequent pull-down experiments with native
proteins in vitro confirmed that the interaction between LC3B
and ELKS1 is direct (Fig. 5j); while co-immunoprecipitation
studies and immunofluorescence analysis in mouse neurons
indicated that endogenous LC3 and ELKS can associate in the
brain in-vivo (Fig. 5k–n). Interestingly, only cytoplasmic LC3 was
found in the complex with ELKS1 in neuronal cells (Fig. 5l),
where they both localized to en passant presynaptic terminals
(Fig. 5m).
CLASP2-dependent regulation of MTs stability via LC3/
ELKS1. Taken into account the ELKS1 association with LC3 in-
vitro and in-vivo, we next analyzed ELKS1 levels in neurons
lacking the LC3 lipid conjugation machinery. We found that
slightly more ELKS1 was co-immunoprecipitated with LC3 in
ATG5 KO neurons (Fig. 6a). Furthermore, impairment of LC3
lipid conjugation was generally associated with significantly
higher levels of ELKS1 in cultured neurons (Fig. 6b, c, Supple-
mentary Fig. 6c) and in brains of ATG5 KO mice (Supplementary
Fig. 6d, e), where it was enriched at the presynaptic boutons
(Fig. 6d–f). Interestingly, the degradation of ELKS1 was
autophagy-independent per se (Fig. 6g), but was found to require
the proteasome (Supplementary Fig. 6f, g), similarly to its Dro-
sophila homolog Bruchpilot43. Furthermore, in cells over-
expressing the LC3B G120A mutant and treated with the
proteasome inhibitor MG132 the amount of ELKS1 was sig-
nificantly higher than that in LC3B wildtype-expressing cells
(Supplementary Fig. 6h, i). LC3B G120A also decreased ELKS1
protein turnover (examined upon inhibition of protein synthesis
using cyclohexamide) (Supplementary Fig. 6k, m), while deletion
of LC3B in ATG5 KO neurons via siRNAs smart pool-mediated
gene KD normalized ELKS1 protein levels in axons (Fig. 6h–j).
An attractive scenario suggests that the autophagy-independent
regulation of ELKS1 protein levels by LC3 lipid conjugation
machinery is responsible for the MT stability phenotype observed
earlier. In agreement with this hypothesis, deletion of ELKS1 in
autophagy-deficient neurons was sufficient to rescue impaired
MTs dynamics, monitored by overexpression of EB3-tdTomato
in control and ATG5 KO neurons (Fig. 6k, Supplementary
Fig. 6n–q). These results taken together with the fact that the KD
of both LC3A (Supplementary Fig. 6r) and LC3B (see Fig. 2s)
decreases the area of axonal swellings in ATG5 KO neurons,
indicate that LC3A/B lipid conjugation machinery non-
canonically regulates MT dynamics via an ELKS1-dependent
mechanism.
In non-neuronal cells ELKS regulates MT dynamics via its
interaction with the MT-associated proteins CLASPs (Cytoplas-
mic linker associated proteins)44. Since endogenous ELKS1 and
brain-enriched CLASP245 associate in the brain in-vivo (Supple-
mentary Fig. 6s), we next speculated that axonal ELKS1 regulates
MT dynamics via stabilizing the levels of its binding partner
CLASP2. Consistent with our hypothesis, we found that the levels
of CLASP2, tested by specific antibody (Supplementary Fig. 6t–w),
were significantly upregulated in brains of autophagy deficient
mice (Fig. 6n, o) and that CLASP2 was more abundantly
associated with ATG5 KO MTs resolved by superresolution
STED microscopy (Fig. 6p, Supplementary Fig. 6x). Although
CLASP2 was not degraded by the proteasome per se, we observed
that its protein levels were also stabilized by LC3B G120A in a
proteasome-dependent manner (Supplementary Fig. 6j, l), while
the siRNA-mediated downregulation of ELKS1 was sufficient to
reduce the CLASP2 levels in ATG5 KO axons (Fig. 6q,
Supplementary Fig. 6y). Finally, by performing an EB3 comet
assay in CLASP2 overexpressing control neurons, we found that
CLASP2 abundance directly decreases MT catastrophe frequency
and increased the length of MT growth events (Fig. 6r–u),
suggesting that CLASP2 protects MTs against depolymerization,
by reducing the number of dynamic plus ends. CLASP2 was not
regulating the polymerization rate of the remaining plus-ends,
since the mean velocity of EB3 comets was not significantly
altered by CLASP2 overexpression (Fig. 6v). These data, taken
together with the fact that several MT plus-end tracking proteins,
required for retrograde trafficking, localize to the ends of
tyrosinated (dynamic), but not detyrosinated (stable) MTs46,
suggest that increased stabilization of MTs by CLASP2 without
the ATG5 might impair the retrograde cargo trafficking in axons.
Impaired BDNF/TRKB signaling in ATG5 KO brains.
Decreased MT dynamics in ATG5 KO neurons might have severe
consequences for cargo delivery to the cell body and affect neu-
ronal plasticity. A crucial pathway that promotes neuronal plas-
ticity is the brain-derived neurotrophic factor (BDNF) signaling
pathway. BDNF initiates signaling by binding to its receptor
Fig. 4 LC3 lipid conjugation machinery regulates MT dynamics. a, b Time-lapse images and corresponding kymographs of WT and ATG5 KO axons co-
expressing Tubulin-eGFP and EB3-tdTomato. Arrows indicate EB3 comets in WT neurons. c EB3 comet density in WT and ATG5 KO axons, expressing
either eGFP (WTGFP: 0.05 ± 0.01, KOGFP: 0.02 ± 0.00) or eGFP-ATG5 (WTATG5: 0.05 ± 0.00, KOATG5: 0.06 ± 0.01). *pWTGFP vs. KOGFP= 0.032,
*pKOGFP vs. KOATG5= 0.019. N= 3 independent experiments. d, e Levels of tyrosinated (Y) (78.28 ± 3.12%, **p= 0.001) and detyrosinated (deY) (69.85
± 13.75%, *p= 0.047) α-Tubulin in dynamic ATG5 KO MTs. N= 5 independent experiments. f–h Δ2α-Tubulin levels in immunostained (f) and lysed (g, h)
cultured WT and ATG5 KO neurons (KO: 136.13 ± 16.78%). *p= 0.049. N= 5 independent experiments. Scale bars, 50 µm. i, j Levels of tyrosinated (Y)
(82.25 ± 5.75%, *p= 0.045) and detyrosinated (deY) (134.49.25 ± 9.09%, *p= 0.032) α-Tubulin in polymerized ATG5 KO MTs. N= 3 independent
experiments. k–m Δ2α-Tubulin levels in in immunostained (k) and lysed (l, m) cultured WT and ATG16L1 KO neurons (KO: 136.18 ± 10.79%). *p= 0.039.
N= 3 independent experiments. Scale bars: 50 µm. n–p Representative images, kymographs and comet density of EB3-tdTomato-expressing WT (0.07 ±
0.01) and ATG16L1 (0.03 ± 0.01) KO axons. *p= 0.029. N= 3 independent experiments. q, r Representative kymographs and comet density in EB3-
tdTomato-expressing axons, transfected with either eGFP (0.061 ± 0.006), eGFP-LC3B (0.054 ± 0.001) or eGFP-LC3B G120A (0.035 ± 0.005). **peGFP vs.
eGFP-LC3B G120A= 0.009, peGFP vs. eGFP-LC3B= 0.413. N= 3 independent experiments. s, t Representative kymographs and comet density in EB3-
tdTomato-expressing axons, co-transfected either with eGFP (0.049 ± 0.003), eGFP-LC3B G120A (0.028 ± 0.003) or eGFP-GABARAP G116A (0.060 ±
0.008), *peGFP vs. eGFP-LC3B G120A= 0.044, peGFP vs. eGFP-GABARAP G116A= 0.321. N= 3 independent experiments. All graphs show mean ± SEM, statistical
analysis was performed by unpaired two-tailed Student’s t‐test in (p), two-way ANOVA for multiple comparisons in (c), one-way ANOVA for multiple
comparisons in (r, t) and one-sample Student’s t‐test in (e, h, j, m). n.s.-non-significant. In (e, h, j, m) KO protein levels were normalized to the WT set to
100%. In (e, h, j, m) samples arise from the same experiment and the blots were processed in parallel such that one loading control was used. Total
number of neurons in N experiments is shown in Supplementary Table 3. Source data are provided as a Source Data file. Scale bar for all kymographs
x: 5 µm, y: 20 s.
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TRKB in distal neurites47 and the retrograde transport of BDNF-
activated TRKB receptors is required for the autocrine regulation
of nuclear Bdnf expression48. Given the fact that retrograde
transport of TRKB receptors is impaired in ATG5 KO neurons
(see Fig. 3) one would expect the BDNF/TRKB signaling to be
reduced in these cells. As predicted, we observed that levels of
BDNF-activated TRKB (p-TRKBY816), as well as the activation
of its main downstream targets ERK1/2 and AKT were sig-
nificantly decreased in ATG5-deficient neurons (Fig. 7a, b). In
agreement with autocrine regulation of Bdnf gene expression, the
levels of Bdnf mRNA, but not the mRNA levels of TrkB were
significantly reduced in the absence of ATG5 (Fig. 7c, d). This
phenotype was also accompanied by a severe reduction in mTOR
activity (Fig. 7e, f), likely as a result of diminished BDNF
signaling.
Our previous data indicate that conditional loss of ATG5
results in defective neuronal arborization35, a phenotype which
might be a consequence of a failure in BDNF/TRKB signaling.
Thus, we boosted the BDNF signaling through exogenous
sustained application of BDNF to cultured WT and ATG5 KO
neurons. Interestingly, although axonal dystrophy persisted under
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was sufficient to prevent the loss of dendritic complexity and
induce mTOR activation in autophagy-deficient neurons
(Fig. 7g–j, Supplementary Fig. 7b–d). Under similar conditions,
nerve growth factor (NGF) application failed to rescue the mTOR
signaling in ATG5 KO neurons (Supplementary Fig. 7e).
Finally, since dynamic MTs are crucial for synapse remodeling
during long-term memory formation11, a phenotype, which
requires the BDNF/ERK1/2-dependent activation of immediate
early genes, such as c-Fos49, we hypothesized that impaired MT
dynamics in combination with decreased BDNF/TRKB signaling
will have severe consequences for memory acquisition in ATG5
deficient mice. To test this, we analyzed the c-Fos gene activation
in the hippocampus of control and autophagy-deficient mice after
acquiring the memory on a novel object in the open field arena
(Novel Object Recognition test, NOR). We examined c-FOS
protein levels 90 min after testing session performed 24 h after
learning (Fig. 7k). The number of c-FOS positive neurons in the
dentate gyrus was significantly decreased in mice conditionally
lacking ATG5 (Fig. 7l), indicating that the ablation of the LC3
conjugation machinery in excitatory neurons arrests the NOR-
dependent neuronal activity in the hippocampus.
Discussion
Our data unravel an unexpected function of autophagy ubiquitin-
like conjugation machinery in neurons. We show that ATG5 and
ATG16L1 proteins, involved in LC3 lipid conjugation, are dis-
pensable for survival of forebrain excitatory neurons. Instead,
mammalian neurons capitalize on the autophagy lipidation
machinery to regulate the stability of axonal MTs and maintain
the branching complexity via modulating the transport of axonal
cargo, including BDNF-activated TRKB receptors and
mitochondria.
In neurons, stable MTs are known to provide tracks for cargo
transport over long distances, while labile MTs are important for
rapid reorganization of the cytoskeleton during synaptic plasti-
city, a function which can be especially crucial at highly dynamic
en passant boutons50, representing the majority of forebrain
synapses51. Here we report that axonal pathology in autophagy-
deficient neurons occurs mostly at cortical en passant–like
synapses. Our data are consistent with the model according to
which modest stabilization of MTs in the absence of the autop-
hagy lipidation machinery prevents local remodeling of cytoske-
leton at presynapses, a phenotype causing axonal swellings of
long-distance cortical axons. Together with the observation that
the reduction of dynamic MTs diminishes the transport of
axonal cargo52, our results predict that decrease in MT dynamics
under autophagy-deficient condition impairs retrograde axonal
signaling required for synaptic plasticity. Indeed recent data have
shown that MT-stabilizing drug Paclitaxel, which is used to treat
a wide spectrum of tumors, including breast and ovarian cancer,
causes dysregulation of BDNF signaling53 accompanied by
memory dysfunctions in mice54 and humans55, akin to the loss of
ATG5 reported here.
In contrary to previously described direct association of LC3
with MTs39, we find that regulation of MT stability in neurons is
promoted by a protein complex comprising the AZ protein
ELKS1 and its brain-enriched MT-binding partner CLASP2.
CLASP2 belongs to the family of plus-end tracking proteins,
which specifically accumulate at the growing MT plus-ends to
mediate the MT attachment to cortical regions56. This function
CLASPs requires their interaction with ELKS1 (also known as
ERC1 or CAST2)44, a protein, which in neurons constitutes a part
of the cytomatrix of the AZ and is enriched at presynaptic
terminals42. Several lines of evidence suggest that the regulation
of neuronal MT dynamics requires the interaction of cytoplasmic
LC3 with ELKS1. First, we demonstrate that neuronal LC3
associates with ELKS1 both in-vitro (Fig. 5j) and in-vivo (Fig. 5k,
l). Second, upregulation of cytoplasmic LC3 levels stabilizes
ELKS1 protein levels via inhibition of its proteasomal degradation
(Fig. 6b–f, Supplementary Fig. 6f–m), while LC3 knockdown
downregulates ELKS1 levels in ATG5 KO background (Fig. 6h–j).
Finally, we demonstrate that knockdown of ELKS in autophagy-
deficient neurons is sufficient to restore the impaired MT
dynamics and diminish axonal pathology (Fig. 6k–m). The
interaction of ELKS1 with LC3 is likely of special importance at
cortical en-passant synaptic boutons, which maintain the neu-
rotransmitter release with a frequency of 100 Hz57. Such intense
activity places presynaptic proteins at a high risk of damage, a
phenotype that requires effective retrograde transport of damaged
and misfolded proteins to the cell soma for degradation58. Thus,
we suggest a model according to which autophagy lipidation
machinery functions at presynaptic terminals to regulate axonal
retrograde transport by temporally adjusting the dynamics of
MTs polymerization rates to intense cycles of exo/endocytosis of
synaptic vesicles30. It is possible, if not likely, that the metabolic
state of the presynapse will provide the precise temporal resolu-
tion for control of MTs-based transport in neurons. For instance,
AMPK-dependent induction of autophagy59 would decrease the
amount of cytoplasmic LC3, thereby increasing the amount of
dynamic MTs ends, which will facilitate the MT-based transport
of axonal cargo.
Previously, indirect association between MTs and LC3 has been
shown to require the MT-associated proteins MAP1A and
MAP1B38 or their homolog MAP1S60. Taken into account the fact
that the expression of MAP1B is restricted to neonatal brain61,
Fig. 5 LC3 directly associates with ELKS1 in-vitro and in-vivo. a Mass spectrometry analysis of LC3 interaction partners in the brain. Volcano plot
illustrates the significantly abundant proteins. The −log10 is plotted against the log2 (fold change: LC3/control). The non-axial vertical lines denote ±2-fold
change while the non-axial horizontal line denotes p= 0.05, which is the significance threshold. b–d Ectopically expressed ELKS1, tagged with tdTomato is
co-immunoprecipitated (Co-IP) with eGFP-tagged LC3A (b) and LC3B (c), but not with GABARAP (d). HEK cell lysates were directly analyzed (Input) or
subjected to GFP immunoprecipitation (Elution) and further immunoblotted against mCherry (Co-IP). Input, 1% of the total lysate. e–g Ectopically expressed
ELKS1, tagged with tdTomato is co-immunoprecipitated (Co-IP) with eGFP-tagged LC3A G120A (e) and LC3B G120A (f) but not with GABARAP G116A (g).
HEK cell lysates were directly analyzed (Input) or subjected to GFP immunoprecipitation (Elution) and further immunoblotted against mCherry (Co-IP).
Input, 1% of the total lysate. h, i Ectopically expressed LC3A and LC3B, tagged with eGFP are co-immunoprecipitated with tdTomato-ELKS1. HEK cell lysates
were directly analyzed (Input) or subjected to ELKS1 immunoprecipitation (Elution) and further immunoblotted against GFP (Co-IP). Input, 1% of the total
lysate. j Purified recombinant His6-LC3B, detected by immunoblotting with LC3B antibody, directly binds Myc-ELKS1. Input, 12.5% of the total recombinant
LC3B and Myc-ELKS1. k Co-immunoprecipitation of endogenous ELKS1 with LC3B form mouse brain lysate. Input, 4% of the total lysate was added to the
assay. l Co-immunoprecipitation of endogenous LC3B with ELKS1 form mouse brain lysate. Input, 4% of lysate. m, n Close colocalization of tdTomato-ELKS1
and eGFP-LC3B at en passant presynaptic boutons marked by synapsin immunofluorescence (blue). Colocalization is analyzed by Mander´s overlap
coefficient (80.42 ± 7.22%). Scale bars: 5 µm (upper panel), 1 µm (lower panels). N= 2 independent experiments. All graphs show mean ± SEM. Co-IP
experiments in HEK cells represent examples from N= 3 independent experiments. Source data are provided as a Source Data file.
NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-020-15287-9 ARTICLE
NATURE COMMUNICATIONS |         (2020) 11:1535 | https://doi.org/10.1038/s41467-020-15287-9 | www.nature.com/naturecommunications 11
while MAP1A and MAP1S are predominantly localized to den-
drites62, our results provide a mechanism of how LC3 might reg-
ulate axonal MTs stability in the adult mammalian brain.
Neuronal-confined KO of several ATG genes causes neurode-
generation63. Despite of these findings and more than 50 years of
autophagy research, the precise physiological function of ATG
proteins in promoting neuronal survival remained elusive. Our
data reveal a non-canonical role for autophagy lipidation
machinery in regulation of MT stability in the axon and raise an
intriguing possibility that neurodegeneration observed under
autophagy-deficient conditions might at least partially arise from
altered MT dynamics. Further studies will be needed to test this
hypothesis. However, based on our results we suggest that
pharmacological activation of autophagy in the brain may not
only promote the degradation of bulk cytoplasmic material, but
also impair the axonal integrity via altering the MT stability.
Methods
Animals. C57/BL/6 mice were housed in polycarbonate cages at standard 12/12
day-night cycles, and water and food were provided ad libitum. All animal
experiments were approved by the ethics committee of LANUV Cologne and were
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A451). Tamoxifen-inducible ATG5 KO mice (ATG5flox/flox: B6.Cg-Tg(CAG-cre/
Esr1*)5Amc/J) were described previously35. Forebrain confined ATG5 KO mice
were created by crossing of Atg5flox/flox mice with the CamKIIα-Cre line22.
Atg16l1flox/flox mice64 were received from Prof. Philip Rosenstiel (University
Hospital Kiel, Germany). Forebrain confined ATG16L1 KO mice were created by
crossing of Atg16l1flox/flox mice with the CamKIIα-Cre line22. Tamoxifen-inducible
ATG16L1 KO mice were created by crossing Atg16l1lox/lox mice with CAG-cre/
Esr1 line (The Jackson Laboratory). Ai9(RCL-tdT) line was received from Dr.
Matteo Bergami (CECAD, Cologne, Germany). GFP-LC3 mice (Riken) were
described previously65.
Preparation of neuronal cultures and transfections. Neuronal cell culture.
Cortical and hippocampal neurons were isolated from postnatal mice at p1–5 as
previously described66. In brief, neuronal cultures were prepared by surgically
removing the cortices and the hippocampi from postnatal mice at p1-5, followed by
trypsin digestion to dissociate individual neurons. Neurons were grown in a MEM
(Gibco) medium, containing 0.5% Glucose (Sigma), 0.02% NaHCO3 (Roth) and
0.01% Transferrin (Merck), which was further supplemented with 5% FBS (Sigma),
0.25% L-GlutMax (100×, Gibco), 2% B27 (50×, Gibco), 1% Pen/Strep (10000
Units/ml Penicillin, 10,000 µg/ml Streptomycin, Gibco). After two days in-vitro
2 mM AraC was added to the culture medium to limit glial proliferation. To initiate
homologous recombination, primary neurons isolated from floxed animals
expressing a tamoxifen-inducible Cre recombinase were treated with 0.4 μM (Z)-4-
hydroxytamoxifen (Sigma) immediately after plating. After 24 and 48 h, cells were
treated with 0.2 µM and 0.4 µM of tamoxifen, respectively, during medium renewal.
Ethanol was added to control neurons (WT) in an amount equal to the tamoxifen.
Plasmid and siRNA transfections. Neurons were transfected at DIV 7–9 days
using an optimized calcium phosphate protocol with Calcium Phosphate
transfection kit (Promega)66. For this 6 mg plasmid DNA, 250 mM CaCl2 and
water (for each well of a 6-well plate) were mixed with equal volume of 2× HEPES
buffered saline (100 ml) and incubated for 20 min allowing for precipitate
formation, while neurons were starved in NBA medium for the same time at 37 °C,
5% CO2. Precipitates were added to neurons and incubated at 37 °C, 5% CO2 for
30 min. Finally, neurons were washed twice with HBSS medium and transferred
back into their conditioned medium. In case of siRNAs smart pool knockdown
experiments, eGFP plasmid was always co-transfected with 100 nM siRNAs (see
Supplementary Table 2) on DIV-7-9 to identify the morphology of the axons in
transfected cells, and neurons were always analyzed 5 days posttransfection.
Treatment with BDNF and ß-NGF. Neurons were supplied with 50 ng/mL of
recombinant BDNF or ß-NGF (PAN Biotech) (the same amount of water was used
as a control) at DIV 2, 6, 10, and 14. Neurons were fixed or harvested at DIV 16 for
ICC or WB, respectively.
Stereotaxic injection of AAV9-CamKIIα-eGFP. Stereotactic injections were
performed on 12–13-week-old Atg5flox/flox:CamKIIα-Cre WT and KO mice. Mice
were anesthetized with a mixture of Ketamin (100 mg/kg)/Xylazin (20 mg/kg)/
Acepromazine (3 mg/kg) and mounted in a Kopf stereotactic frame. For the
injection, a small hole was made in the skull of the mouse and a 1 µl Hamilton
syringe filled with 300 nl of AAV9-CamKIIα-eGFP was lowered into the M1 area of
primary motor cortex, using following coordinates: AP-1.25, DL-1.8, Depth-0.52. A
volume of 300 nl AAV was delivered during 5 min, with a 5-min delay after the
penetration, and waiting another 15 min before withdrawing of the syringe. The
animal was given a dose of carprofen to reduce postsurgical pain (s.c, 5 mg/kg)
before the end of the surgery. Suturing the skin over the wound completed the
surgery and the animal was then allowed to recover. Animals were sacrificed by
transcardial perfusion 10–14 days after surgery, and the eGFP expression was
analyzed by confocal microscopy (see Immunohistochemical analysis of brain
sections).
Plasmids. Rat LC3B sequence (GeneID: 64862) was cloned in ptagRFP-C vector
(Gift from Dr Michael Kreutz) using Bgl II and EcoRI restriction enzymes. For
generating the LC3BG120A, Glycine at 120 was mutated to alanine, and a stop
codon was introduced after the alanine 120 by side-directed mutagenesis. All
plasmids used in the study are listed in the Supplementary Table2. Mouse LC3A
sequence (Gene ID: 66734) was cloned into pEGFP-C vector (a gift from Dr
Michael Kreutz) using EcoRI and BamHI restriction enzymes. For generating the
LC3AG120A, Glycine at 120 was mutated to alanine. Mouse GABARAP sequence
(GeneID: 56486) was cloned from cDNA derived from the cortex, using Hind III
and BamHI restriction enzymes. GABARAPG116A construct was generated by
mutating glycine at position 116 to alanine.
Immunocytochemistry and analysis of cultured neurons. Neurons were fixed at
DIV 16–18 in 4% paraformaldehyde (PFA, Merck) in phosphate-buffered saline
(PBS) for 15 min room temperature (RT), washed and blocked with PBS con-
taining 5% normal goat serum (NGS, Thermo Scientific) and 0.3% Saponin (Serva)
for 1 h. Neurons were incubated with primary antibodies (see Supplementary Table
1) for 1 h in PBS containing 10% NGS (Thermo Scientific) and 0.3% Triton X-100
(Roth). Coverslips were rinsed three times with PBS (10 min each) and incubated
with corresponding secondary antibodies (see Supplementary Table 1) for 30 min
(diluted 1:500 in PBS containing 0.3% TritonX and 10% NGS). Subsequently,
coverslips were washed three times in PBS and mounted in Immu-Mount (Thermo
Scientific)35. Fixed neurons were imaged using either Zeiss Axiovert 200M
microscope equipped with 40x/1.4 oil DIC objective and the Micro-Manager
software (Micro-Manager1.4, USA) or with Leica SP8 confocal microscope (Leica
Microsystems) equipped with a ×63/1.32 oil DIC objective and a pulsed excitation
white light laser (WLL; ∼80-ps pulse width, 80-MHz repetition rate; NKT Pho-
tonics). For quantitative analysis of fluorescent protein levels (or fluorescent
puncta), the area of the neuron, cell body, axon or spheroid (depending the
experiment) was manually selected using ImageJ selection tools (ROI) and the
mean gray value was quantified within the ROI after the background subtraction.
Spheroid was defined as axonal swelling larger than 2 µm in diameter. Fluorescent
puncta were determined by applying the autothreshold “minimum” algorithm
implemented in ImageJ and analyzed using the “Analyze particles” ImageJ module
to determine the number of fluorescent puncta per 1 µm2. For quantifying the
number of neurons containing axonal swellings, the coverslips were imaged by
using EVOS FL Auto 2 (Invitrogen, USA). For quantifying the number of spheroids
per axon, the number and the diameter of spheroids from WT and KO neurons
were analyzed for the last 300 µm of the axon by the ImageJ. The number of
dendritic spines was quantified per 10 µm of primary dendrite per neuron.
Immunostaining of α-tubulin in cultured neurons. Neurons were treated on DIV
16 either with 0.2 µg/ml Nocodazole (Sigma) or with 0.2 µg/ml DMSO for 1 h.
Afterwards, they were rinsed with warm PHEM buffer (60 mM PIPES, 25 mM
HEPES, 10 mM EGTA, 4 mM MgCl2), followed by an incubation step in PHEM
buffer containing 0.05% Triton-X-100 (Roth) and a protease inhibitor cocktail
(Roche) at 37 °C for 1.5 min to remove the soluble Tubulin. Then, neurons were
fixed with cold methanol (−20 °C) for 8 min, permeabilized and blocked with PBSS
(PBS containing 0.2% saponin (Serva), and 2.5% BSA, Sigma) for 30 min at RT and
incubated with primary antibodies diluted in PBSS for 2 h (see Supplementary
Table1). Coverslips were rinsed twice in PBSS (2 min each) and incubated with
corresponding secondary antibodies (diluted 1:500) in PBSS for 30 min. Finally,
Fig. 6 LC3 regulates MTs stability via ELKS1/CLASP2-dependent mechanism. a ELKS1 and LC3B Co-IP in WT and ATG5 KO lysates. Input, 10% of lysate.
b, c ELKS1 levels in ATG5 WT and KO lysates. *p= 0.022. d–f ELKS1 colocalization with Bassoon in WT and ATG5 KO cortex, analyzed by Pearson’s
correlation coefficient. *p= 0.04. Scale bar, 10 µm, 2 µm inserts. g ELKS1 levels in NSC34 cells treated with 67 nm BafilomycinA for 16 h. h–j Decreased
ELKS1 levels in eGFP-transfected ATG5 KO neurons, treated with LC3b siRNA, *p= 0.010. Scale bars, 10 µm, 4 µm inserts. k EB3 comet density in WT and
ATG5 KO axons, transfected either with scr or Elks1 siRNA. *pWTscr vs. KOscr= 0.025, **pKOscr vs. KOsiElks1= 0.004, *pWTscr vs. WTsiElks1= 0.041.
l, m Spheroid area is decreased in eGFP-transfected ATG5 KO axons treated with Elks1 siRNA, compared to scr siRNA. *p= 0.018. Scale bars, 5 µm, 3 µm
inserts. n, o Increased CLASP2 levels in ATG5 KO cortex. *p= 0.046. In (n), CLASP2 fluorescence was false color-coded with warm colors representing
high intensities. Scale bars, 50 µm, 10 µm inserts. p STED imaging of CLASP2 localization on WT and ATG5 KO MTs. Scale bars, 1 µm. q CLASP2 levels in
ATG5 KO axons treated either with scr or Elks1 siRNA. **p= 0.004. r–v EB3 comet density (eGFP: 0.052 ± 0.00; eGFP-CLASP2: 0.0417 ± 0.004, *p=
0.012), MT catastrophe frequency (eGFP: 0.021 ± 0.001 s−1, eGFP-CLASP2: 0.015 ± 0.001 s−1, *p= 0.017), MT growth events length (eGFP: 53.39 ± 2.35 s,
eGFP-CLASP2: 70.93 ± 4.85 s, *p= 0.017) and MT growth rate (eGFP: 0.289 ± 0.042 µm * s−1, eGFP-CLASP2: 0.322 ± 0.055 µm * s−1, p= 0.654) in
neurons, transfected either with eGFP or eGFP-CLASP2. Scale bar, x: 5 µm, y: 20 s. Data in b, c, f, j, k, m, q are from N= 3 independent experiments. Data in
o, s–v are from N= 4 independent experiments. All graphs show mean ± SEM, statistical analysis was performed by unpaired two-tailed Student’s t‐test in
(f, m, s–v), two-way ANOVA for multiple comparisons in (k) and one-sample Student’s t‐test in (c, j, o, q). In (c, o) KO was normalized to WT, in (j, q)
KOsi was normalized to KOscr. n.s.-non-significant. Total number of neurons in N experiments is shown in Supplementary Table 3. Source data are provided
as a Source Data file.
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coverslips were washed four times in PBSS and mounted in Immu-Mount (Thermo
Scientific).
STED imaging. Cultured cortical/hippocampal neurons were fixed under MTs
stabilization conditions. In brief, a 3-min extraction at RT in PEM buffer (2%
polyethylene glycol (Mr 10,000), 100 mM PIPES-KOH, pH 6.9, 1 mM MgCl2, 1 mM
EGTA) containing 1% Triton X-100 (Thermo Scientific) and 2 μM taxol was fol-
lowed by a quick rinse in PBS before fixation with 3.7% PFA and 0.5% glutar-
aldehyde in PEM buffer for 20 min. Subsequent MT extraction of neurons was
performed by using 0.5% Triton X-100 (Roth), 5% BSA in PBS, followed by
antibody incubation without further blocking reagents or detergents. Coverslips
were mounted in ProLong Gold (Thermo Fisher Scientific). STED imaging with
time-gated detection was performed using a commercial SP8 gSTED ×3 micro-
scope (Leica Microsystems), equipped with a pulsed excitation white light laser
(WLL; B80-ps pulse width, 80-MHz repetition rate; NKT Photonics) and two
STED lasers for depletion (continuous wave at 592 nm, pulsed at 775 nm). The
pulsed 775-nm STED laser was triggered by the WLL. Within each independent
experiment, samples were acquired with equal settings. Alexa 488 and Alexa 532
were excited using a pulsed WLL at 488 and 545 nm, respectively. Depletion
occurred at 592 nm. Fluorescence signals were detected sequentially by hybrid
detectors at appropriate spectral regions separated from the STED laser by cor-
responding dichroic filters. Images were acquired with an HC PL APO CS2 ×100/
1.40-N.A. oil objective (Leica Microsystems), a scanning format of 1024 × 1024,
eight-bit sampling, and 4.5 zoom, yielding a pixel dimension of 25.25 nm and
25.25 nm in the x and y dimensions, respectively.
Sholl analysis of cultures neurons. Neurons were transfected with eGFP on DIV
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Plan-Apochromat ×63/1.32 Oil DIC objective, corrected for both chromatic and
spherical aberrations and analyzed as previously described35. In brief, Sholl analysis
of single neurons was performed using the ImageJ Sholl Analysis Macro. The
complexity of neuronal branching was calculated by summing the number of
intersections within 200 μm from the cell body.
Live imaging of cultured neurons. Neurons were imaged on DIV 16-19 (or at
DIV 6 in Supplementary Fig. 2x) at 37 °C in imaging buffer (170 mM NaCl,
3.5 mM KCl, 0.4 mM KH2PO4, 20 mM N-Tris[hydroxyl-methyl]-methyl-2-ami-
noethane-sulphonicacid (TES), 5 mM NaHCO3, 5 mM glucose, 1.2 mM Na2SO4,
1.2 mM MgCl2, 1.3 mM CaCl2, pH 7.4) using Zeiss Axiovert 200M microscope
(Observer. Z1, Zeiss, USA) equipped with 63x/1.40 Oil DIC objective, a pE-4000
LED light source (CoolLED) and a Hammatsu Orca-Flash4.O V2 CMOS digital
camera. Time-lapse images of neurons expressing TRKB-mRFP were acquired
every second using Micro-Manager software (Micro-Manager1.4, USA) for 30 s. In
the case of experiments with EB3-Tdtomato, Mito-Cherry, eGFP-CLASP2, eGFP-
LC3B, eGFP-LC3BG120A, eGFP-GABARAPG116A plasmids videos were acquired
every second for 60 s. Kymographs were generated using the software Kymo-
Maker67 and analyzed by ImageJ. To analyze the number of EB3 comets, small
axonal fragments were selected from individual neurons and the number of
comets/μm was quantified manually from the kymographs. To monitor the exo-
cytosis of synaptic vesicles via SYB2-pHluorin assay, neurons were subjected to
electrical field stimulation at 50 Hz for 4 s using an RC-47FSLP stimulation
chamber (Warner Instruments) and imaged as described above (time-lapse images
were acquired every second for 2 min). To prevent the activation of postsynaptic
receptors, 10 μM CNQX and 50 μM AP-5 were added to the imaging buffer prior to
imaging. To determine the specificity of MT based transport of TRKB-mRFP
carrier vesicles, DIV15-16 neurons were treated with 20 μm Ciliobrevin D (EMD
Millipore Corp, USA) for 3 h prior to the live cell imaging.
Live and dead neurons were analyzed using LIVE/DEAD™ Cell Imaging Kit
(Thermo Fisher Scientifics). Following manufacture indications, an equal amount
of imaging buffer was mixed with the dye and added to WT and ATG5 KO
neurons (DIV 16) for 15 min at RT. Subsequently, neurons were imaged using
Zeiss Axiovert 200M microscope (Observer. Z1, Zeiss, USA) equipped with ×20
objective, a pE-4000 LED light source (CoolLED) and a Hammatsu Orca-Flash4.O
V2 CMOS digital camera. The analysis was performed using ImageJ.
Synthesis of cell-permeable LC3B peptide. LC3B peptides corresponding to the
amino acid sequence 108-125 (GeneID: 67443) were attached N-terminally to a
cell-penetrating peptide (CPP) sequence, namely sC18*68. For control, LC3B
peptide sequence was scrambled and fused to the CPP. Peptides were synthesized
on Wang resin (loading was 15 mmol) using an automated solid phase peptide
synthesizer (MultiSyntech, Syro I), and following standard Fmoc/tBu-strategy. For
each coupling step, 7 equivalents of Fmoc-amino acid and 7 equivalents of acti-
vation reagents (ethyl-2-cyano-2-(hydroxyimino)acetate (Oxyma) and N,N’-diiso-
propylcarbodiimide (DIC)) were used. N-terminal labeling with 5,6-
carboxytetramethylrhodamine (Tamra) was achieved by using 3 equivalents of
Tamra and 3 equivalents Oxyma and DIC, respectively. All reactions were per-
formed in DMF (dimethylformamide). Following, peptides were cleaved by incu-
bating the resin for 3 h with a mixture of concentrated trifluoracetic acid (TFA)/
1,2-ethanedithiol (95/5 (v/v)). Subsequently, peptides were precipitated in ice-cold
diethyl ether, washed and lyophilized. All peptides were purified using preparative
reversed-phase (RP) HPLC (Hitachi Elite LaChrom (VWR), RP18 column
Nucleodur C18ec, 100–5 (Macherey-Nagel)) at 6 mLmin−1 and 220 nm detection.
Acetonitrile/water with 0.1% TFA were used as eluents, changing gradient as
needed. Fractions were pooled and lyophilized. Identity was proven by LC-ESI-MS
(RP-HPLC from Agilent coupled to an ESI LTQ XL (Thermo) using a Chromolith
Performance RP-18e column, 100 × 4.6 mm from Merck, and using a gradient of
10–60% acetonitrile (0.1% formic acid) in water (0.08% formic acid) over 15 min
and a flow rate of 0.6 mLmin−1. Purities were >95%. LC3B (108–125): (Tamra-
GLRKRLRKFRNKFLYMVYASQETFGTAMAV): 3997.2 Da (calc.), 3997.4 (exp.)
Scr: (Tamra-GLRKRLRKFRNKGFESMAAYVMTVYQALFT): 3997.2 Da
(calc.), 3997.4 Da (exp.).
Analysis of axonal swellings in GFP-LC3B transgenic neurons. Cortical and
hippocampal neurons were isolated from postnatal GFP-LC3B transgenic mice at
p1–5 as previously as described above. Neurons were treated at DIV15 with 5 μM
of LC3B or scrambled peptide for 3 h at 37 °C. Following treatment neurons were
washed with HBSS medium and further incubated in the medium for 15 h. Live cell
images were acquired using Zeiss Axiovert 200M microscope with ×10 objective
lens. Total number of neurons was quantified from each image and swellings were
represented as a percentage of total neurons.
Electron microscopy. Neurons cultured on 18 mm Ø coverslips were fixed with
pre-warmed fixative solution (2% glutaraldehyde, 2.5% sucrose, 3 mM CaCl2,
100 mM HEPES, pH 7.4) at RT for 30 min, followed by the post-fixation at 4 °C for
30 min. Afterwards, the cells were washed with 0.1 M sodium cacodylate buffer,
incubated with 1% OsO4, 1.25% sucrose, 10 mg/ml K4[Fe(CN)6]·3 H2O in 0.1 M
cacodylate buffer for 1 h on ice and washed three times with 0.1 M cacodylate
buffer. Subsequently, the cells were dehydrated at 4 °C using ascending ethanol
series (50, 70, 90, 100%, 7 min each), incubated with ascending EPON series
(EPON with ethanol (1+ 1) for 1 h; EPON with ethanol (3+ 1) for 2 h; EPON
alone ON; 2 × 2 h with fresh EPON at RT) and finally embedded for 48–72 h at 62 °
C. Coverslips were removed with liquid nitrogen and heat, consecutively. Ultrathin
sections of 70 nm were made using an ultramicrotome (Leica, UC7) and stained
with uranyl acetate for 15 min at 37 °C and lead nitrate solution for 4 min. Electron
micrographs were taken with a JEM-2100 Plus Electron Microscope (JEOL),
Camera OneView 4 K 16 bit (Gatan) and software DigitalMicrograph (Gatan).
Novel object recognition test. The novel object recognition (NOR) was per-
formed on 12–13-week-old Atg5flox/flox:CamKIIα-Cre WT and KO mice in a white
painted square box (50 × 50 × 40 cm), illuminated with >20 lux. The objects used in
the test included a blue colored cool pack and a diverse colored cube. The objects
differed in height, width, color and shape and no preference for one of the objects
was determined in preliminary experiments. Mice were monitored during the
session by a digital camera placed above the arena and connected to a video
tracking system (EthoVision®XT, Noldus). Animals were handled for 5 min on
three successive days prior to the test session. Habituation to the environment was
performed 60 min before the test sessions, exposing the animal to the open field for
5 min. Two training session (60 min interval) were performed with two copies of
one object, placed in the back left and right corners of the box, followed by the test
session 24 h later with one object used in the training sessions and one novel object.
The animals were exposed for 5 min to the objects and each mouse was placed
individually at the mid-point of the wall opposite to the objects with its nose
pointing away from the objects. Mice were sacrificed via transcardial perfusion (see
below) 90 min after the test session.
Immunohistochemical analysis of brain sections. Mice were sacrificed at 12–15
weeks-old by an overdose of ketamine/xylazine (i.p., 10 µl per 10 g body weight)
and transcardially perfused with 50 ml saline solution (0.85% NaCl, 0.025% KCl,
0.02% NaHCO3, pH 6.9, 0.01% heparin, body temperature), followed by 50 ml cold
Fig. 7 Loss of MT dynamics in ATG5 KO neurons impairs neurotrophin signaling and compromises the learning and memory-dependent neuronal
activation. a, b TRKB signaling is significantly decreased in lysates from cultured ATG5 KO neurons compared to the WT set to 100% (KOp-TRKB: 54.68 ±
16.78%, *p= 0.027; KOp-ERK: 73.34 ± 9.94%, *p= 0.028; KOp-Akt: 64.70 ± 10.82%, *p= 0.016). N= 5 independent experiments. c Bdnf mRNA levels are
significantly decreased in cultured ATG5 KO neurons (KOBdnf: 12.35 ± 2.88%, KOGapdh: 98.79 ± 0.36%). ***p < 0.000. N= 4 independent experiments.
d TrkB mRNA levels are non-altered in ATG5 KO neurons (KOTrkB: 81.25 ± 8.37%, KOGapdh: 98.79 ± 0.36%). e, f Protein levels of phosphorylated S6
Ribosomal Protein (pS6) in lysates from cultured WT and ATG5 KO neurons (KO: 40.39 ± 14.04%). *p= 0.016. N= 4 independent experiments. g ATG5
KO neurons expressing eGFP were treated either with BDNF or with H2O and subsequently immunostained for MAP2. Scale bar, 50 µm. g, h Application of
BDNF rescues the branching complexity of ATG5 KO neurons compared to H2O-treated KO controls (KOBDNF: 146.55 ± 9.88, KOH2O: 69.98 ± 4.72, **p=
0.001). N= 4 independent experiments. See also Supplementary Fig. 7 for detailed Sholl analysis. i, j pS6 protein levels are significantly increased in lysates
of ATG5 KO neurons treated with BDNF (KO: 175.16 ± 36.20%), comparing to H2O-treated KO controls (KO: 46.61 ± 6.40%). *p= 0.049. N= 3
independent experiments. k Representative confocal images of c-FOS labeled nuclei (green) in the dentate gyrus in WT and ATG5 KO mice sacrificed after
acquiring the memory on novel object recognition. To reveal the neurons, sections were co-immunostained for NeuN (magenta). Scale bars, 800 µm,
200 µm inserts. l The number of c-FOS-labeled nuclei is significantly decreased in the dentate gyrus of mice lacking ATG5 (75.12 ± 8.88%) when compared
to the WT. *p= 0.020. N= 4 independent experiments. All graphs show mean ± SEM, statistical analysis was performed by unpaired two-tailed Student’s
t‐test in (f, m, s, t, u, v, l), paired Student’s t‐test in (h) and one-sample Student’s t‐test in (b, c, d, f, j). In all graphs the KO was normalized to the WT set
to 100%. n.s.-non-significant. Total number of neurons in N experiments is shown in Supplementary Table 3. Source data are provided as a Source Data file.
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(7–15 °C) freshly depolymerized 4% (wt/vol) PFA (Merck) in 0.1 M PBS, pH 7.4.
Brains were carefully taken out of the skull, postfixed overnight in the same fixative,
and placed in a mixture of 20% (vol/vol) glycerol (Roth) and 2% (vol/vol) dime-
thylsulfoxide (VWR International) in 0.4 M PB for 24 h for cryoprotection Free-
floating sections (40 μm) were made using freezing Microtome KS34 (Microm
GmbH) and collected in six series in 0.1 M PBS. For immunostaining, corre-
sponding horizontal 40 µm sections from WT and KO littermates were washed
three times in PB (3 × 15 min each), followed by permeabilization with PB con-
taining 0.3% Triton X-100 (9 × 20 min each). Sections were preincubated with PB
containing 5% (vol/vol) NGS (Thermo Scientific) and 0.3% Triton X-100 (Roth)
for 1 h and subsequently incubated with primary antibody at 4 °C for 48 h (see
Supplementary Table1). Then, sections were washed 9 times for 20 min each in
0.3% Triton X-100 in 0.125M PB and incubated with Alexa-conjugated secondary
antibodies (1:500) for 2 h using standard techniques. The sections were washed
three times for 15 min each in 0.125M PB. Finally, sections were mounted on
gelatin-coated glass slides. Sections were imaged either at a resolution of 1024 ×
1024 (or at 2048 × 2048 in Fig. 6d, e), with eight-bit sampling (no z increment was
used) with a Leica SP8 confocal microscope ((Leica Microsystems), using a Plan-
Apochromat ×63/1.32 oil DIC objective, corrected for both chromatic and sphe-
rical aberrations.
Nissl staining. Horizontal brain sections were obtained from perfused 13-week-old
ATG5 KO and ATG16L1 KO mice and processed for cresyl violet staining. For
that, the sections were mounted in 0.2% gelatine solution in 250 mM Tris-HCl and
dried overnight at 40 °C on a heating plate. Mounted sections were re-hydrated for
1 min in water and stained for 5–10 min in 0.1% cresyl violet solution. Subse-
quently, sections were rinsed three times (2 min each) in water and dehydrated
using an ascending ethanol series (50, 70, 80, 90%) for 2 min each. After rinsing the
sections in 96% ethanol, they were destained with 0.5% acetic acid and washed
twice in 100% ethanol (2 min each), incubated with xylene for 2 min and subse-
quently mounted using Entellan35.
Western blot. Mice were sacrificed at 12–14 week-old by cervical dislocation.
Brains were dissected and immediately placed into liquid nitrogen to be stored at
−80 °C for further use or directly homogenized with a Wheaton Potter-Elvehjem
Tissue Grinder in radioimmunoprecipitation assay (RIPA) buffer, containing 50
mM Tris pH 8.0, 150 mM NaCl, 1.0% IGEPAL CA-630, 0.5% Sodium deox-
ycholate, 0.1% SDS and protease inhibitor cocktail (Roche), sonicated and incu-
bated for 1 h on ice for the protein extraction. To extract protein from cortical/
hippocampal primary cultures, neurons were harvested at DIV16-18 with RIPA
buffer containing protease inhibitor and phosphatase inhibitor cocktail (Thermo
Scientific), sonicated, and placed for 30 min on ice. The lysates were centrifuged at
17.0×g at 4 °C and supernatants were collected. Protein concentrations were
determined by Bradford assay (Sigma). Starvation was induced by incubating the
cells at 37 °C/5% CO2 ON for 16 h in osmolarity-adjusted Earle’s Balanced Salt
Solution (EBSS, Gibco). In order to study the levels of acetylated α-tubulin, neu-
ronal cultures were harvested with a lysis buffer containing 6M Urea, 50 mM Tris,
150 mM NaCl, 0.1% SDS, 1% Triton, pH 7.4. Depending on the experiment 2–20
µg of total protein were loaded onto gel and separated by SDS-PAGE, and then
transferred to a nitrocellulose or PVDF membrane. Membranes were blocked for 1
h at RT in 5% skim milk (or with BSA) in TBS buffer (20 mM Tris pH= 7.6, 150
mM NaCl) containing 0.1% Tween (TBS-T) and incubated with the primary
antibodies overnight at 4 °C (see Supplementary Table1), followed by washing
three times (10 min each) with TBS-T. Afterwards membranes were incubated with
secondary antibodies diluted in 5% skim milk or BSA in TBS-T buffer for 1.5 h at
RT. After the incubation, membranes were washed three times as above and
subsequently developed using ECL-based autoradiography film system. The ana-
lysis was performed using Image J Analyze Gel plugin. For quantification, protein
levels were always first normalized to the loading control and then the levels in the
KO were normalized to the WT set to 100%.
Extraction of MT fractions. To fractionate soluble and polymerized MTs from
cultured neurons, first the lysis Buffer A1 (137 mM NaCl, 20 mM Tris-HCl, 1%
Triton X-100 and 10% Glycerol) was added to the cells at DIV 16 at 4 °C for 3 min,
plates were gently swirled two to three times, and the supernatant was collected as a
soluble fraction69. Immediately after, polymerized tubulin was extracted using lysis
Buffer B (Buffer A+ 1% SDS), which was added to the cells for 1 min and the cells
were harvested as polymerized fraction. To isolate dynamic MTs, first the soluble
fraction was extracted at DIV 16 with the lysis Buffer A2 containing 137 mM NaCl,
20 mM Tris-HCl and 0.1% digitonin (Sigma) for 10 min at RT. Next, to induce the
depolymerization of stable MTs, the neurons were incubated with Buffer A2 at 4 °C
for 1 h. The supernatant was collected and saved as dynamic MT fraction. Cold-
stable MTs were extracted with Buffer B (Buffer A2+ 1% SDS). Collected MT
fractions were briefly sonicated and analyzed by Western blotting as
described above.
Co-immunoprecipitation assays. To immunoprecipitate α-tubulin from cultured
WT and ATG5 KO neurons, first soluble MT fraction was extracted as described
above (under “Extraction of MT fractions”). Remaining cells were then incubated
with the Co-IP buffer (50 mM Tris-HCl, 1% NP-40, 100 mM NaCl, 2 mM MgCl2,
protease inhibitor (Roche), pH 7.4) and the extraction of polymerized tubulin were
performed by incubating the cell lysates at 4 °C for 45 min. Following incubation,
the lysates were centrifuged at 0.9 × g for 5 min at 4 °C and supernatants were
collected and used as polymerized fractions for immunoprecipitation (IP) assay.
For the IP Dynabeads Protein G (Invitrogen) were coupled either to α-tubulin
antibody or to equivalent amount of non-specific IgG as a control. After the
coupling, the unbound antibody was removed by carefully placing the tubes on the
magnetic bar. Antibody-coupled Dynabeads were then incubated with soluble and
polymerized tubulin fractions. For the IP from the soluble fraction the Dynabeads
were incubated overnight at 4 °C to avoid the polymerization of tubulin, while the
polymerized fraction was incubated for 1 h at RT. Samples were then washed 3
times using Co-IP buffer. Proteins were eluted in 4xSDS sample buffer and ana-
lyzed by Western blotting. For other Co-IP experiments, cultured WT and ATG5
KO neurons (DIV 15-16) or whole mouse brain were homogenized and extracted
in Co-IP buffer. Equal amount of cell lysates was added to the Dynabeads Protein
G coupled to the target antibody or the non-specific IgG as a control. The samples
were further processed as above.
For experiments in HEK293T cells, cells were maintained in DMEM medium
(GIBCO), containing 10% FCS, penicillin (255 Units/ml) and streptomycin (255
µg/ml). Twenty-four hours after seeding, the cells were transfected with eGFP or
eGFP-LC3B, eGFP-LC3BG120A, eGFP-LC3A, eGFP-LC3A G120A, eGFP-
GABARAP or eGFP-GABARAP G116A along with tdTomato-ELKS1. Following
20 h of overexpression cells were harvested and lysed with the RIPA buffer and
immunoprecipitation assays were performed by incubating the cell lysates with
magnetic GFP-microbeads (Miltenyibiotech, Germany). The samples were
analyzed by WB as described above.
Knockdown experiments in MEF or NSC-34 cells. Mouse embryonic fibroblasts
(MEFs) or mouse motor neuron-like hybrid cell line (NSC-34) were maintained in
DMEM medium (GIBCO), containing 10% FCS, penicillin (255 Units/ml) and
streptomycin (255 µg/ml) (in case of MEF cells, 1% MEM NEAA (Gibco) were
supplemented to the medium). The cells were transfected with 300 pM siRNA
using Lipofectamine RNAiMAX Reagent (Thermo Fisher). Gene silencing was
achieved by two consecutive rounds of transfections with the interval of 24 h. 48 h
after the first transfection cells were harvested and cell lysates were then
analyzed by WB.
Cyclohexamide and MG132 treatment in HEK293T and NSC34 cells. For the
cycloheximide assay, HEK293T cells were transfected with eGFP, eGFP-LC3B or
eGFP-LC3BG120A plasmids. Twelve hours post-transfection cells were incubated
with 5 μM of cycloheximide. Following 0, 4, 8, and 24 h of incubation cells were
harvested in RIPA buffer and samples were analyzed by WB. For the MG132 assay,
HEK293T were treated with 5 μM of MG132 (Sigma) or DMSO (dimethyl sulf-
oxide) as a control. NSC34 cells were treated with 10 µM of MG132 for 24 h.
Seahorse assay. The seahorse assay was performed to measure the OCR (oxygen
consumption rate) in ATG5 WT/KO neuronal cultures at DIV 13. Neuronal cul-
tures were prepared as described above and plated in a PDL-coated 96-well XF
tissue culture plate (Agilent) at a concentration of 20,000 cells/well. Blank vials
were distributed equally over the plate, 4 vials were analyzed per genotype. The
XFp sensor cartridges were hydrated overnight with XF calibrant at 37 °C. For the
measurement/treatment three port A-C were loaded with 10x concentration of
mitochondrial inhibitors as stated by the user guide of the Seahorse XFp Cell Mito
Stress Test kit (cat-103010-100; Agilent Technologies). Each treatment lasted for
15 min, including 3 measurement time points. The first episode was used to
establish the baseline, before sequential injection of oligomycin (1 µM), FCCP (1
µM), rotenone and antimycin A (both 0.5 µM). Data processing was performed
using WAVE software version 2.6.0.
Mass spectrometry analysis of LC3 binding partners. Brains of 8 weeks old WT
mice were homogenized in 2 ml Co-IP buffer (see above). Brain lysates were stored
for 45 min on ice before centrifugation at 17,0 × g for 20 min at 4 °C. The super-
natants were collected and the protein concentration was assessed by Bradford. The
magnetic Dynabeads (Protein G, Invitrogen) coupled to LC3 or IgG antibody as a
control were incubated with 8.8 mg of the supernatant overnight on 4 °C on a
shaker. Next day, the beads were washed three times with Co-IP buffer before they
were transferred into fresh tubes and re-dissolved in 20 µl Co-IP buffer and 4x SDS
buffer. After boiling the samples at 95 °C for 5 min the samples were loaded onto
SDS-PAGE gels, reduced (DTT) and alkylated (CAA). Digestion was performed
using trypsin at 37 °C overnight. Peptides were extracted and purified using
Stagetips. Eluted peptides were dried in vacuo, resuspended in 1% formic acid/4%
acetonitrile and stored at −20 °C prior MS measurement. All samples were ana-
lyzed on a Q-Exactive Plus (Thermo Scientific) mass spectrometer that was coupled
to an EASY nLC 1000 UPLC (Thermo Scientific). Peptides were loaded with sol-
vent A (0.1% formic acid in water) onto an in-house packed analytical column (50
cm × 75 µm I.D., filled with 2.7 µm Poroshell EC120 C18, Agilent). Peptides were
chromatographically separated at a constant flow rate of 250 nl/min using the
following gradient: 5–27% solvent B (0.1% formic acid in 80% acetonitrile) within
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40 min, 27–50% solvent B within 8 min, followed by washing and column equili-
bration. The mass spectrometer was operated in data-dependent acquisition mode.
The MS1 survey scan was acquired from 300–1750m/z at a resolution of 70,000.
The top 10 most abundant peptides were isolated within a 1.8 Da window and
subjected to HCD fragmentation at a normalized collision energy of 27%. The AGC
target was set to 5e5 charges, allowing a maximum injection time of 110 ms.
Product ions were detected in the Orbitrap at a resolution of 17,500. Precursors
were dynamically excluded for 10 s. All mass spectrometric raw data were pro-
cessed with Maxquant (version 1.5.3.8) using default parameters. Briefly,
MS2 spectra were searched against the Uniprot MOUSE.fasta database, including a
list of common contaminants. False discovery rates on protein and PSM level were
estimated by the target-decoy approach to 1% (Protein FDR) and 1% (PSM FDR)
respectively. The minimal peptide length was set to 7 amino acids and carbami-
domethyolation at cysteine residues was considered as a fixed modification. Oxi-
dation (M) and Acetyl (Protein N-term) were included as variable modifications.
The match-between runs option was enabled. LFQ quantification was enabled
using default settings. The Maxquant output was processed using the Perseus
computational platform. Protein groups flagged as „reverse“, „potential con-
taminant“ or „only identified by site“ were removed from the proteinGroups.txt.
Statistical analysis of log2-transformed LFQ values was performed using a one-
sided t-test. Correction for multiple testing was achieved by a permutation based
FDR-approach. The mass spectrometry proteomics data have been deposited to the
ProteomeXchange Consortium via the PRIDE (PubMed ID: 26527722) partner
repository with the dataset identifier PXD011279 [https://www.ebi.ac.uk/pride/
archive?keyword=PXD011279].
Quantitative RT-PCR. RNA isolation was performed using Trizol (Thermo Fisher
Scientific)35. Twenty nanogram of total RNA was used for reverse transcription
using the High Capacity cDNA Reverse Transcription Kit (Applied Biosystems)
following the manufacturer´s instructions. qPCR was performed with qPCRBIO
SyGreen Mix Kit (Applied Biosystems) in a 7500 Fast System. Gapdh housekeeping
expression was evaluated using two other housekeeping genes, Rrn18s and Hprt1.
qPCR analysis of the mRNA expression of pro-survival and pro-apoptotic genes
was performed using a universal PCR master mix and TaqMan probes (Applied
Biosystems; Bcl2l1/Bcl-xL: Mm00437783_m1, cflar/cFlipL: Mm01255580_m1,
Dtit3/Chop: Mm00492097_m1, Bax: Mm00432051_m1) and the Ct values were
normalized to TATA-box-binding protein (Tbp) that was used as reference gene.
Relative expression of gene transcripts was assessed using the 2-ΔΔCt method70.
In-vitro pull-down. Full-length human LC3B was expressed from pRSF-Duet-1
(G2P) as His6-tagged fusion protein. The expression was performed in Escherichia
coli BL21 (DE3). The cells were harvested by centrifugation (15 min, 1.5 xg, 4 °C),
resuspended in buffer A (100 mM NaCl, 50 mM Tris/HCl pH 7.4, 5 mM MgCl2, 2
mM β-mercaptoethanol, 100 µM Pefabloc) and lysed by sonication. The His6-LC3B
containing supernatant after centrifugation (45 min, 33,600 × g) was loaded onto an
equilibrated Ni-NTA column (Ni Sepharose 6 Fast Flow, GE Healthcare) using
buffer B (100 mM NaCl, 50 mM Tris/HCl pH 7.4, 5 mM MgCl2, 2 mM β-mer-
captoethanol) plus 20 mM imidazole. The column was washed with 10 column
volumes of washing buffer C (300 mM NaCl, 50 mM Tris/HCl pH 7.4, 5 mM
MgCl2, 20 mM imidazole, 2 mM β-mercaptoethanol) and the His6-LC3 protein
eluted using a 20 mM to 500 mM Imidazole gradient in buffer B. The His6-LC3B
containing fractions were pooled and concentrated using a 3 kDa MWCO Amicon
ultrafiltration unit for the subsequent size-exclusion chromatography on a HiLoad
26/600 Superdex 75 pg column (GE Healthcare) in buffer D (50 mM HEPES pH
7.9, 100 mM NaCl, 5 mM MgCl2, 2 mM β-mercaptoethanol, Roth). The His6-LC3
containing fractions were pooled, shock-frozen in liquid nitrogen and stored at
−80 °C. Purified recombinant MYC/DDK tagged human ERC1 protein was pur-
chased from (OriGene CAT#: TP313864). For the assay 2 µg of His6-LC3B was
mixed with 1 µg of MYC/DDK-ERC1 in reaction buffer (50 mM Tris, pH 7.6, 500
mM NaCl, 5 mM MgCl2, 2 mM β-mercaptoethanol, 10% glycerol, 30 mM Imida-
zole) with 30 µl of Ni-NTA magnetic agarose beads (Qiagen). For the control group
only MYC/DDK-ECR1 was added to the Ni-NTA magnetic beads. The reaction
mixture was incubated for 1 h at 4 °C with gentle shaking. Following the incuba-
tion, the beads were washed three times with the reaction buffer and proteins were
eluted from the beads by adding 4× SDS-PAGE sample buffer and the samples
were analyzed by immunoblotting using ELKS1 and LC3B antibodies.
Statistical analysis and reproducibility. For analysis of experiments, statistically
significant estimates were obtained from at least three independent experiments
(indicated as N in figure legends), which represent biological replicates. The exact
number of neurons used for single independent experiments in indicated in Sup-
plementary Table 3. Graphs and statistical analysis was made with GraphPad Prism
(GraphPad Software 8.0.1). Statistical tests used are given in the figure legend of the
corresponding experiment. The statistical significance between two groups for all
normally distributed raw data except growth factor treatments was evaluated with a
two-tailed unpaired student’s t test. Effect of BDNF on neuronal complexity were
evaluated using paired student’s t tests. The statistical significance between more
than two groups for all normally distributed raw data was evaluated using either
One-Way ANOVA with Dunnett’s posthoc test or Two-Way ANOVA repeated
measures with Tukey posthoc test for multiple comparisons. All normalized data
were evaluated using one-sample student’s t test. Statistical significance on variables
obtained from Sholl analysis was calculated using two-way ANOVA with repeated
measurements after data normalization using Ln transformation. Significant dif-
ferences were accepted at p < 0.05. All shown representative WB images or
micrographs are examples from minimum N= 2 independent experiments.
Supplemental information. Supplemental Information includes Supplementary
Tables 1–3 and 8 supplementary figures and can be found with this article online.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
All data supporting the findings described in this study are available from the
corresponding author upon reasonable request. Source data from all representative blots
shown in this study as well as data underlying all quantitative analysis performed in this
study are provided with the manuscript as a Source Data file. Uncropped WB
membranes for representative WB images are shown in Supplementary Fig. 8. Mass
spectrometry data have been deposited in the ProteomeXchange Consortium via the
PRIDE (PubMed ID: 26527722) partner repository with the dataset identifier
PXD011279.
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